Program
Printable Schedule (PDF)
Preliminary Program (380 KB PDF)
| Monday, September 25, 2006 | |
| 6:00pm-7:30pm | Opening Reception |
| 7:00pm-9:00pm | VC Dinner (by invitation only) |
| Tuesday, September 26, 2006 | |
| 7:30am-8:30am | Continental Breakfast |
| 8:00am-8:30am | Welcoming Remarks: |
| The Honorable James C. Greenwood, President and CEO, BIO | |
| Ohio Governor Bob Taft | |
| 8:30am-9:15am | Opening Keynote Session: Connect and Develop with the Fortune 500 |
| Speaker: Mark Collar, President Global Pharmaceuticals & Personal Health, The Procter & Gamble Company | |
| 9:30am-12:30pm | Presentations |
| 9:45am-11:00am | Alternative Capital Sources Workshop: The New Bioscience Start-up Investors: Hedge Funds, Foundations, and Angels |
| Panel: Russell Bromley, Chief Operating Officer, Myelin Repair Foundations; John Huston, Founding Member, Ohio Tech Angel Fund; Morton Cohen, Chairman and CEO, Clarion Capital; Peter Kleinhenz, Managing Director, CID Capital, Inc.; Kevin McGinty, Founder and Managing Director, Peppertree Capital Management, Inc. and Peppertree Partners | |
| 11:15am-12:30pm | Investing in Innovation Workshop: Promise and Pitfalls of Investing in Cutting-Edge Technologies: Stem Cells, Personalized Medicine, and Nanotech |
| Panel: Gil Van Bokkelen, Ph.D., Chairman & CEO, Athersys, Inc.; Charles Baltic III, Managing Director, Wachovia Securities; Walt Linscott, Esq., Managing Partner, Atlanta Chair, Life Sciences Practice, Thompson Hine LLP; Sean Murdock, Executive Director, NanoBusiness Alliance | |
| 12:30pm-2:00pm | Luncheon Keynote: The Molecular Metamorphosis: A New Reality for Health Care |
| Speaker: Andrew von Eschenbach, M.D., Acting FDA Commissioner | |
| 2:15pm-5:00pm | Presentations |
| 2:30pm-3:45pm | State Growth Initiative Workshop: Catalyzing Entrepreneurship Through Progressive Programs |
| Panel: Dan Berglund, President and CEO, State Science and Technology Institute; John Rice Ph.D., Managing Partner, Triathlon Medical Ventures; Lynn Allen, President, Capital Innovations, Inc.; Alfred Brown Ph.D., President, BCM Technologies; Mark Regal, Director, Alternative Capital, Credit Suisse; John Neis, Managing Director, Venture Investors LLC | |
| 4:00pm-5:15pm | Globalization Workshop: New Opportunities for Early-Stage Companies: Suppliers, Markets, and Investors |
| Panel: Amit Patel, M.D., M.S., Director, Center For Cardiac Cell Therapy, University of Pittsburgh Medical Center Heart Lung & Esophageal Institute; Thomas Bradshaw, President and CEO, Ricerca Biosciences, LLC; Jack Merritt, President and CEO, Icon Interventional Systems, Inc.; Bruce Roberts, Co-Founder and Managing Director, Roberts Mitani, LLC; Morrie Ruffin, CEO, Life Tech Innovations, LLC | |
| 6:00pm-8:30pm | Gala Reception |
| Wednesday, September 27, 2006 | |
| 8:00am-9:30am | Continental Breakfast |
| 8:30am-9:45am | Plenary Session: Institutional Collaborations to Commercialize Start-Up Products |
| Panel: Joseph Hahn, M.D., Chief of Staff, The Cleveland Clinic Foundation; Donald Harrison, M.D., Managing Director, Charter Life Sciences; Robin Silva, Partner, Chair of Life Sciences and Health Care, Dorsey & Whitney LLP; Fred Rothstein, M. D., President and CEO, University Hospitals of Cleveland | |
| 10:00am-12:00pm | Presentations |
| 10:30am-11:45am | Regulatory Workshop: Strategies for Accelerating The Biopharmaceutical and Medical Device Regulatory Approval Process |
| Panel: Vincent Bucci, President, Health Policy Associates, Inc.; Clinton White, MBA, Ph.D., Group Director, Project Management, Global Internal Medicine Unit, Quintiles Transnational Corp.; Edward Pardon, M.D., J.D., Associate, Michael Best & Friedrich LLP; Patrick McBrayer, President and Chief Executive Officer, AxioMed Spine Corporation; Christopher Mullin, Senior Statistical Consultant, Integra Clinical Trial Solutions | |
| 12:00pm-12:45pm | Luncheon |
| 1:00pm-2:15pm | Presentations |
| 1:00pm-2:15pm | Accelerating Healthcare Clusters Workshop: Successful, Short-Term Models |
| Panel: Baiju Shah, President and CEO, BioEnterprise; Dr. Avshalom Horan, Managing Partner, Bridge Investment Fund; Walter Plosila, Ph.D., Vice President, Technology Partnership Practice, Battelle Memorial Institute; Michael Rosen, Senior Vice President New Business Development, Science and Technology Group, Forest City Enterprises, Inc.; Murray Mclaughlin, Ph.D., Director Business Development, Canadian Light Source; W. Steven Burke, Senior Vice President, North Carolina Biotechnology Center | |
| 2:15pm | Closing Reception |